.Attribute Medicine, Posted online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Standpoint calls for incorporation of clients along with MASLD and measurement of liver outcomes in cardio-- renal-- metabolic tests, when data advise mechanistically conceivable benefits as well as medical safety-- as well as summarizes factors to consider for test layout and regulatory commendation.